ArticleVaccines2025

CD63-Mediated SARS-CoV-2 RBD Fusion Neoantigen DNA Vaccine Enhances Antitumor Immune Response in a Mouse Panc02 Model via EV-Targeted Delivery.

Guang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.